MedPath
NMPA Approval

Lecanemab Injection

国药准字SJ20240001

EISAI INC.

January 5, 2024

Drug Information

仑卡奈单抗注射液

乐意保

注射剂

200mg(2ml)/瓶

生物制品

January 5, 2024

January 4, 2029

Company Information

Applicant Company

EISAI INC.

200 Metro Blvd., Nutley, NJ 07110 United States of America

Manufacturing Company

biogen us corporation

900 Davis Drive, Research Triangle Park, NC 27709 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

仑卡奈单抗注射液 - NMPA 批准文号 | MedPath